Korro Bio (KRRO) Revenue (2019 - 2025)

Korro Bio (KRRO) has reported Revenue for 5 consecutive years, with $1.3 million the latest figure, recorded in Q4 2025.

• For the quarter ending Q4 2025, Revenue fell 43.11% year-over-year to $1.3 million; the trailing twelve-month figure through Jun 2026 stood at $2.4 million (down 62.08% YoY), and the FY2025 full-year result was $6.4 million, up 181.46% from the prior year.
• Revenue advanced to $1.3 million in Q4 2025 per KRRO's latest filing, from $1.1 million in the prior quarter.
• Across five years, Revenue topped out at $9.4 million in Q2 2021 and bottomed at $1.1 million in Q3 2025.
• Historically, Revenue has averaged $3.2 million across 3 years, with a median of $2.3 million in 2024.
• The sharpest annual moves came in 2021 and 2025: Revenue grew 10.49% in 2021, then sank 43.11% in 2025.
• Over 3 years, Revenue stood at $9.4 million in 2021, then slumped by 75.88% to $2.3 million in 2024, then tumbled by 43.11% to $1.3 million in 2025.
• According to Business Quant data, Revenue over the past three periods registered $1.3 million, $1.1 million, and $1.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.